Back

Risk assessment in patients with low-flow, low-gradient aortic stenosis undergoing TAVI

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Cutting edge transcatheter heart failure therapeutics Intervention HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Mariana Caetano Coelho

Hospital de Santa Marta, Lisbon (Portugal)

5 More presentations in this session

Presentation thumbnail
Tricuspid regurgitation in patients undergoing mitral valve surgery for primary mitral regurgitation
Assistant Professor K. Lodin (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Impact of treatment modality on prognostic features in patients with severe tricuspid regurgitation
Doctor K. Kresoja (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Two-year outcomes of mitral transcatheter edge-to-edge repair in patients with heart failure and functional mitral regurgitation from the MiCLASP Study
Doctor K. Rommel (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Impact of ejection fraction based heart failure classification on TAVI related outcomes
Doctor Y. Sener (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
De novo conduction disturbances after TAVI: what to expect?
Doctor D. Da Silva Correia (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Cutting edge transcatheter heart failure therapeutics

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Clinical outcomes and predictors of mortality in TAVI patients with high, low and very low baseline gradient. Analysis of the Spanish TAVI registry
thumbnail
Congress Session
Predictors of TAVI outcomes
thumbnail
Congress Session
Deep dive into aortic stenosis: new imaging insights

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources